Stay up-to-date on the latest information about Blue Cross Blue Shield Association and how we’re advancing our mission to help all Americans live their healthiest lives.
New research from BCBSA and Blue Health Intelligence demonstrates the clear health and financial benefits of preventive cancer screenings
The Blue Cross and Blue Shield Federal Employee Program® (FEP®) announced a $1 million contribution to the Federal Employee Education and Assistance Fund (FEEA), to aid those federal employees and their families who are hardest hit by the government shutdown with cash grants and no-interest loans.
Planned knee and hip replacement procedures continue to climb in cost and volume, according to a review of medical claims data from Blue Cross Blue Shield Association (BCBSA).
Blue Cross Blue Shield Association Senior Vice President of Government Programs William A. Breskin issued the following statement today on federal employees’ health care coverage during the government shutdown.
Blue Cross Blue Shield Association President and CEO Scott Serota issued the following statement today in regard to the U.S. District Court ruling on the Affordable Care Act.
Prescription drug spending among branded specialty and patent-protected drugs continues to outpace generic drugs at $79.5 billion, according to an update to last year’s study of medical claims by the Blue Cross Blue Shield Association (BCBSA).
Blue Cross Blue Shield Association (BCBSA) and Illumina, Inc. today announced an important partnership to determine the availability and clinical understanding of DNA sequencing technologies, genetic testing and precision medicine across the country in an effort to provide patients with expanded access to personalized medicine.
Subscribe to stay in the know on health care industry news and insights.